ArticleOncoTargets and therapy2011

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.

Eva Muñoz-Couselo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.